Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
BOSTON Pfizer’s search for a holding company to handle public relations duties for its cardiovascular franchise has concluded with the selection of WPP, said the company.
In November, the New York-based client had invited WPP, Interpublic Group and Omnicom Group to each assemble PR teams to pitch the account. Omnicom dropped out of the process at an earlier stage.
The budget for the account is undisclosed.
The pharmaceutical giant’s cardiovascular drug line includes the cholesterol-lowering drug Lipitor, as well as Norvasc and Caduet.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in